DVx Inc. Announces Non-Consolidated Earnings Results for the Six Months Ended September 30, 2016; Provides Non-Consolidated Earnings Guidance for the Full Year of Fiscal Year Ending March 31, 2017; Expects to Pay Year-End Dividend for the Fiscal Year Ending March 31, 2017
November 31, 2016
Share
DVx Inc. announced non-consolidated earnings results for the six months ended September 30, 2016. For the period, the non-consolidated company reported net sales of ¥17,132 million, operating income of ¥706 million, ordinary income of ¥664 million, profit of ¥459 million or net income per basic share of ¥40.77 compared to net sales of ¥14,753 million, operating income of ¥592 million, ordinary income of ¥586 million, profit of ¥702 million or net income per basic share of ¥62.33 for the same period last year. Profit before income taxes was ¥663.633 million against ¥1,040.45 million a year ago. Net cash provided by operating activities was ¥723.759 million against ¥632.626 million a year ago. Purchase of property, plant and equipment was ¥33.741 million against ¥77.111 million a year ago. Purchase of intangible assets was ¥8.965 million against ¥17.402 million a year ago.
The company expects to pay year-end dividend of ¥23.00 per share for the fiscal year ending March 31, 2017.
For the full year of fiscal year ending March 31, 2017, the non-consolidated company expects net sales of ¥33,200 million, operating income of ¥1,536 million, ordinary income of ¥1,536 million, profit of ¥1,028 million or net income per basic share of ¥91.17.
DVx Inc. is a Japan-based company mainly engaged in the sale of medical equipment for circulatory system diseases. The Company operates in two business segments. The Arrhythmia segment mainly sells cardiac pacemakers, implantable cardioverter-defibrillators (ICDs), electrode catheters and ablation catheters. The Ischemia segment is engaged in the import and sale of automated contrast medium injectors under the name ACIST, excimer laser angioplasty systems, as well as sale of coronary artery stent products as agency business. The others business is engaged in the sale of neurosurgical products, general surgery related products, gastrointestinal related products, radiation protection supplies, among others.
DVx Inc. Announces Non-Consolidated Earnings Results for the Six Months Ended September 30, 2016; Provides Non-Consolidated Earnings Guidance for the Full Year of Fiscal Year Ending March 31, 2017; Expects to Pay Year-End Dividend for the Fiscal Year Ending March 31, 2017